Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
683-690
Author(s):
David A. Gewirtz, Mona S. Gupta and Sujatha Sundaram
Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
Heterogeneity in the Pathology and Molecular Biology of Breast Cancer
Journal:
Current Genomics
Volume:
3
Page:
477-488
Author(s):
Edward Gabrielson and Pedram Argani
Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Journal:
Current Drug Metabolism
Volume:
3
Page:
491-525
Author(s):
Consuelo Gajate and Faustino Mollinedo
SERMs: Evolutionary Chemistry, Revolutionary Biology
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2089-2111
Author(s):
Chris P. Miller
Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Journal:
Current Gene Therapy
Volume:
2
Page:
307-322
Author(s):
Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers
Telomerase Inhibitors as Anticancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
567-575
Author(s):
Masaharu Akiyama, Teru Hideshima, Nikhil C. Munshi and Kenneth C. Anderson
Targeting Human Telomerase in Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
577-587
Author(s):
Sylvain Huard and Chantal Autexier
Targetin g Human Tel omerase by Antisens e Oligonucleotides and Ribozymes
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
605-612
Author(s):
M. Folini, M. Pennati and N. Zaffaroni
How to Inhibit Telomerase Activity for Cancer Therapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
613-626
Author(s):
Satoru Kyo and Masaki Inoue